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When secondary causes are excluded, mechanisms underlying central nervous system 
angiitis (ACNS) in human immunodeficiency virus (HIV)-infected patients are still not 
understood and optimal treatment remains undefined. We report here a patient with an 
untreated HIV infection who presented multiple ischemic strokes probably due to HIV-
ACNS. ACNS signs on vessel-wall imaging magnetic resonance monitoring retracted 
with combined antiretroviral therapy without adjunct immunosuppressive drugs.
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INtRoDUCtIoN
Between 1 and 5% of patients carrying the human immunodeficiency virus (HIV) will present a 
stroke and up to 30% will display a cerebral ischemic lesion on autopsy. In these cases, stroke can 
be a consequence of opportunistic infections, coagulation abnormalities, meningitis, and vasculitis. 
However, whether HIV-infected patients are predisposed to increased risk of stroke by a direct or 
indirect virus-associated vascular change or because of the atherogenic effect of antiretroviral agents 
remains unclear (1, 2).
Angiitis of the central nervous system (ACNS) is one of the main atiologies of ischemic strokes 
in HIV-positive patients been accounted for 13–28% of the cases. ACNS in a HIV-positive patient 
can be secondary (to opportunistic infections) or due to HIV itself either directly or indirectly 
through modifications in the local immune and inflammatory response. Frequently, the vascu-
lopathy is present without any other discernible disease leading to the diagnosis of HIV-associated 
ACNS (HIV-ACNS) (3, 4). HIV-ACNS cases were mainly reported before the era of combined 
antiretroviral therapy (c-ART) and almost every pattern of vasculitis (inflammatory cells in the 
blood vessel wall together with associated wall damage) of small, medium, and large vessels have 
since been reported (5). Some authors deem HIV-ACNS to be immune mediated and akin to 
primary angiitis of the CNS (3, 6) while others consider HIV-ACNS to be caused by a direct 
action of the HIV (5, 7, 8). A main argument for the direct involvement of HIV in HIV-ACNS is 
the identification of HIV particles (by RNA in situ hybridization and electron microscopy) in the 
perivascular tissues of patients with HIV-ACNS (5). However, this evidence is counterbalanced 
by the histological identification of immune deposits in the vessel walls of the same patients (5).
The optimal treatment for HIV-ACNS remains unknown as only a limited number of case 
reports are available (9–13). In the majority of cases, the introduction of an immunosuppressive 
therapy [extrapolated from evidence from PACNS’s studies (14)] is associated with HIV antiret-
roviral therapy to cover both alleged physiopathological mechanisms of HIV-ACNS. However, 
restoring immunity with c-ART on one hand and inducing immunosuppression on the other hand 
FIGURe 1 | Brain MRI at admission (a–F) and 1 month after treatment initiation (G–L). (a,G) Diffusion-weighted imaging and (B,H) apparent diffusion 
coefficient showing restricted diffusion in the right anterior cerebral artery territory, compatible with a recent ischemic stroke. (C) FLAIR sequence showing 
postischemic lesions in the anterior territory. (I) Extension of the lesion in FLAIR confirming established lesions in right and left anterior cerebral arteries. (D–F,J–L) 
Vessel wall imaging with MRI (VWI-MR), black blood MRI [high-resolution (3-T), black-blood fat suppressed pre- and post-contrast T1 weighted images]. (D–F) 
Concentric contrast enhancements (CEs) suggesting a central nervous system vasculitis (indicated by arrows). (D) CE of a distal branch of the left anterior cerebral 
artery. (e,F) CE of distal branches of the right middle cerebral artery. (J–L) Retraction of the CE after 1 month of combined antiretroviral treatment.
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with immunosuppressive drugs seems paradoxical and precludes 
clear understanding of the underlining pathophysiology when 
patients improve.
Here, we present the case of a 56-year-old man with an 
untreated HIV infection presenting multiple ischemic strokes due 
to a probable case of HIV-ACNS. Vasculitis signs on serial vessel-
wall imaging (VWI-MR) retracted with c-ART without adjunct 
immunosuppressive drugs suggesting that the pathophysiology 
of HIV-ACNS is more likely being directly related to the HIV 
itself than to a immune reaction.
BaCKGRoUND
A 56-year-old man admitted at the emergency room (ER) with 
a recurrent left leg weakness occurring for more than 24 h. The 
individual chart indicated the presence of HIV-1 infection since 
2012 but without antiretroviral treatment. Anamnesis revealed 
that the HIV was sexually transmitted and that the patient had 
never consumed drugs of abuse. On admission, the CD4+ cell 
count was 313/mm3 (15.69% lymphocytes) and HIV-1 viral load 
was 59,375 copies/ml.
Additionally, the patient had a history of syphilitic aortic 
aneurysm treated by Bentall surgery 10 years ago for which he is 
treated with an anti-vitamin K (acenocoumarol, dose adjusted as 
necessary) and concomitantly presents multiple cardiovascular 
risk factor including obesity (BMI =  35), glucose intolerance, 
arterial hypertension, and hypercholesterolemia treated by 
amlodipine and simvastatin.
The weakness in his left leg was first noticed while driving. He 
went to the ER where he recovered completely within 6 h and was 
discharged after an unremarkable brain computed tomography 
angiography. The next day, the patient felt again a left leg weak-
ness and was admitted a second time at the ER.
On this second admission, the general physical examination 
was within normal limits. Neurologic examination disclosed a 
left leg-predominant hemiparesis sparing the face associated 
with pyramidal syndrome. Brain MRI indicated restricted 
diffusion in the right anterior cerebral artery territory, com-
patible with a recent ischemic lesion, and lacunar lesions in 
the left temporo-occipital and right superior frontal region 
(Figure  1). Such atypical stroke pattern led us to perform a 
VWI-MR that demonstrated multiple vascular wall contrast 
enhancement (CE), particularly on distal branches of the mid-
dle (Figures  1E,F) and anterior cerebral artery (Figure  1D). 
Cerebrospinal fluid (CSF) analysis disclosed normal cell count 
and biochemistry. In addition, extensive blood tests and serial 
CSF studies were normal. Syphilitic tests showed a negative 
VDRL and positive TPHA in the blood while these two tests 
were negatives in the CSF. In the CSF, bacterial, mycobacterial, 
fungal, and viral cultures were negatives.
The combination of HIV infection and multiple ischemic 
strokes in different arterial territories associated with the enhance-
ment of cerebral wall vessels both at the stroke territory and at 
other arteries emerging from Willis polygon led to the diagnosis 
of HIV-ACNS. cART (dolutegravir/abacavir/lamivudine) was 
immediately introduced but without adjunct immunosuppressive 
therapy. This was decided based on the patient’s immune status, 
the immediate and complete neurological recovery of this initial 
episode, and the absence of recurrence in the 4 days between the 
patient’s admission and the VWI-MR results.
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After the first month, most vessels did not show CE anymore 
(Figures 1J–L). After 8 months, there was no more CE visible on 
VWI-MR. This clinical course is highly suggestive of isolated CNS 
vasculitis secondary to HIV infection. Unfortunately, 11 months 
after the initial event and 3 months after a VWI-MR devoid of 
vasculitic activity, the patient presented a right sylvian stroke. 
In fact, the INR was measured below the therapeutic threshold 
required for patients who underwent aortic root replacement 
such as the Bentall procedure [INR: 1.72 where it should be 
kept between 2.5 and 3 (15)] and an extensive cardiovascular 
workup (transthoracic and transesophageal echocardiography, 
carotid ultrasonography, 72-h electrocardiogram), which did 
not disclose any intracardiac thrombus, valvular vegetation, 
carotid macroangiopathy neither cardiac arrhythmia. In addi-
tion, reactivation of vasculitic activity was not detectable on a 
new VWI-MR acquisition.
This study was carried out in accordance with the recom-
mendations of Erasme University Hospital ethics committee with 
written informed consent from the patient for the publication of 
this case report.
DIsCUssIoN
We reported here a case of a probable HIV-ACNS whose evolu-
tion was favorable while treated only with c-ART. The case also 
illustrates the potential contribution of VWI-MR to the diagnosis 
of ACNS and the monitoring of disease during treatment.
The patient was admitted at the hospital with a recurrent left 
leg weakness occurring over 24 h, without neither headache nor 
alteration in vigilance, which are both usually seen as classical 
clinical manifestations of PACNS but only found in 54 and 
27%, respectively, of patients (16). When headache is present, 
its characteristics are variable and many authors consider that 
thunderclaps headaches as not characteristic of CNS vasculitis 
but that could suggest, for example, a reversible vasoconstric-
tion syndrome (RCVS) (17). Nevertheless, a focal neurologic 
deficit is found in 83% of PACNS patients and could be the only 
symptom of HIV-ACNS (14). MR brain imaging of this HIV-
positive patient with sudden-onset focal signs was essential both 
for the early diagnosis of ischemic stroke and for the diagnostic 
workup. Once the diagnosis of stroke was confirmed, the clinical 
workup focused on both conventional causes of stroke and also 
on HIV-associated causes. Briefly, the patient had been treated 
with a well-dosed anti-vitamin K drug, protecting him from 
cardioembolic events. Opportunistic infections leading to stroke 
were unlikely, considering relatively high CD4+ level, normal 
serial extensive blood tests, and normal serial cerebrospinal fluid 
studies. For example, VZV infection and tertiary syphilis were 
implausible in front of a normal CSF cell count, biochemistry, 
and index. Although the patient had many cardiovascular risk 
factors, an atheroembolic origin was ruled out since the results 
from doppler sonography of the supra-aortic vessels and mag-
netic resonance angiography were normal. Likewise, a microan-
giopathic origin could have been suspected but was dismissed by 
the MRI lesions localization.
The gold standard for the diagnosis of CNS vasculitis is his-
topathological evidence of vessel wall inflammation. However, 
a brain biopsy is an invasive technique and may reveal false 
negative findings, particularly in patients with predominant or 
isolated proximal large artery involvement (7). Thus, frequently, 
the diagnosis is based on a clinico-radiologic pattern sugges-
tive of the disease. MRI has gained value in this field with the 
development of specific sequences dedicated to vessel walls and 
its inflammation through vessel walls CE detection (18–20).
The CE is visualized with a particular technique based on a 
3DT1-weighted TSE sequence (Black Blood), which better dif-
ferentiate the vessel wall from the lumen blood signal.
Recently, many studies tried to evaluate the performances of 
this technique in PACNS diagnosis and demonstrated that VWI 
could differentiate vasculitis from other vasculopathy-like ath-
erosclerosis and RCVS offering an excellent specificity (18, 19). 
The VWI-MR of the patient was not suggestive of RCVS as 
studies (20, 21) highlight the lack of CE in all included RCVS 
patients. Nonetheless, the patient had many cardiovascular risk 
factors (including HIV infection) and an eventual resulting 
intracranial atherosclerosis could have led to focal vessel wall 
CE. However, the patient’s CE characteristics were not suggestive 
of an atherothrombotic mechanism. Indeed, CE was distal, con-
centric, and visible on important lengths of the involved arteries 
but also on intracranial arteries (middle and posterior cerebral 
arteries) that did not irrigate the infarcted tissues, corroborat-
ing a vasculitic process (19). In a HIV-infected patient, relevant 
differential diagnoses should include HBV and HCV associated 
vasculitis. Indeed, those two viruses are linked to medium vessel 
vasculitis [such as hepatitis B-associated polyarteritis nodosa (22) 
and hepatitis C virus-associated cryoglobulinemia vasculitis with 
brain involvement (23)]. However, those diagnoses were reason-
ably excluded after HBV, HCV, and cryoglobulins tested negative.
An analogy could be drawn between the radiological patterns 
of PACNS and HIV-ACNS, particularly regarding vessel abnor-
malities. Nevertheless, this patient presented certain differences 
with the classical MRI abnormalities found in PACNS. Indeed, 
the patient lacked both the gadolinium meningeal enhancement 
on MRI that is observed in 40.3% of PACNS (14) and the intrac-
ranial haemorrhagic lesions that are also commonly found (16). 
CSF studies have showed both low sensitivity and specificity for 
the discrimination of PACNS from secondary ACNS. However, 
normal CSF studies and negative testing for pathogens such as 
VZV, CMV, EBV, HBV, HCV, toxoplasmosis, Salmonella associ-
ated with ACNS in HIV patients argued for primary involvement 
of the HIV in the vasculopathy of the patient (7, 8).
Some authors have proposed, in case of vasculitis associated 
with HIV infection, to start a systemic immunosuppressive 
treatment in conjunction with c-ART. These recommendations 
are based on rare case reports (9, 11, 12) and were established 
by analogy to what has been done in large observational studies 
of PACNS (14, 16). However, Bhagavati and Choi in 2008 and 
Cutfield et al. in 2009 described two severely immunocompro-
mised HIV-positive patients (CD4+ cell count = 3 and 94 cells/μl, 
respectively) where outcomes improved with cART alone (10, 
24). As described above, the clinical situation of the patient and 
the result of ancillary investigations led us to choose this option. 
Close follow-up was planned with serial neurologic examination 
and VWI-MR. Here, c-ART alone led to a complete retraction of 
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vessel wall CE. All these factors support the diagnosis of HIV-
ACNS driven by HIV infection.
CoNCLUDING ReMaRKs
To the best of our knowledge, this is the first report demonstrat-
ing a complete retraction of vessel wall CE after cART initiation 
without additional immunosuppressive treatment in a so far 
cART-naive HIV patient. It highlights the potential role of dedi-
cated wall vessel sequences on brain MRI for the diagnosis and 
follow-up of HIV-ACNS and its mimics. Further studies are 
required to confirm these preliminary results. The poor outcome, 
despite HIV-ACNS resolution, highlights the further complexity 
of the multiple comorbidities of HIV-infected patients.
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